PP2A Controls Genome Integrity by Integrating Nutrient-Sensing and Metabolic Pathways with the DNA Damage Response

Mol Cell. 2017 Jul 20;67(2):266-281.e4. doi: 10.1016/j.molcel.2017.05.027. Epub 2017 Jun 22.

Abstract

Mec1ATR mediates the DNA damage response (DDR), integrating chromosomal signals and mechanical stimuli. We show that the PP2A phosphatases, ceramide-activated enzymes, couple cell metabolism with the DDR. Using genomic screens, metabolic analysis, and genetic and pharmacological studies, we found that PP2A attenuates the DDR and that three metabolic circuits influence the DDR by modulating PP2A activity. Irc21, a putative cytochrome b5 reductase that promotes the condensation reaction generating dihydroceramides (DHCs), and Ppm1, a PP2A methyltransferase, counteract the DDR by activating PP2A; conversely, the nutrient-sensing TORC1-Tap42 axis sustains DDR activation by inhibiting PP2A. Loss-of-function mutations in IRC21, PPM1, and PP2A and hyperactive tap42 alleles rescue mec1 mutants. Ceramides synergize with rapamycin, a TORC1 inhibitor, in counteracting the DDR. Hence, PP2A integrates nutrient-sensing and metabolic pathways to attenuate the Mec1ATR response. Our observations imply that metabolic changes affect genome integrity and may help with exploiting therapeutic options and repositioning known drugs.

Keywords: DNA damage response; Irc21; Mec1-ATR; Rad53; TORC1; genome stability; metabolism; protein phosphatase PP2A.

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism
  • Ceramides / metabolism
  • Ceramides / pharmacology
  • Cytochrome-B(5) Reductase / genetics
  • Cytochrome-B(5) Reductase / metabolism
  • DNA Damage*
  • DNA Repair* / drug effects
  • DNA, Fungal / genetics
  • DNA, Fungal / metabolism*
  • Energy Metabolism*
  • Enzyme Activation
  • Gene Expression Regulation, Fungal
  • Genome, Fungal* / drug effects
  • Genomic Instability* / drug effects
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Metabolomics
  • Mutation
  • Protein Kinase Inhibitors / pharmacology
  • Protein Methyltransferases / genetics
  • Protein Methyltransferases / metabolism
  • Protein Phosphatase 2 / genetics
  • Protein Phosphatase 2 / metabolism*
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • Saccharomyces cerevisiae / drug effects
  • Saccharomyces cerevisiae / enzymology*
  • Saccharomyces cerevisiae / genetics
  • Saccharomyces cerevisiae Proteins / antagonists & inhibitors
  • Saccharomyces cerevisiae Proteins / genetics
  • Saccharomyces cerevisiae Proteins / metabolism*
  • Sirolimus / pharmacology
  • Transcription Factors / antagonists & inhibitors
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Ceramides
  • DNA, Fungal
  • Intracellular Signaling Peptides and Proteins
  • Protein Kinase Inhibitors
  • Saccharomyces cerevisiae Proteins
  • TAP42 protein, S cerevisiae
  • TORC1 protein complex, S cerevisiae
  • Transcription Factors
  • Cytochrome-B(5) Reductase
  • Ppm1 protein, S cerevisiae
  • Protein Methyltransferases
  • MEC1 protein, S cerevisiae
  • Protein Serine-Threonine Kinases
  • Protein Phosphatase 2
  • Sirolimus